Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cilostazol in these regions, from 2012 to 2022 (forecast).
United States Cilostazol market competition by top manufacturers/players, with Cilostazol sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Teva
Otsuka Pharmaceutical
Novartis
Mylan
Squibb
Sandoz
Hikma Pharmaceuticals
GSK
Mayne Pharma
Bedford Laboratories
Abbott
Takeda
Zhejiang Weikang Pharmaceutical
Chongqing Pharscin pharmaceutical
Chengdu Leer Pharmaceutical
Yantai Yisheng Pharmaceutical
Cadila Pharmaceuticals
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Injection
Freeze-dried Powder
Oral
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cilostazol for each application, including
Hospital
Clinic
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Cilostazol Market Report 2017
1 Cilostazol Overview
1.1 Product Overview and Scope of Cilostazol
1.2 Classification of Cilostazol by Product Category
1.2.1 United States Cilostazol Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Cilostazol Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Injection
1.2.4 Freeze-dried Powder
1.2.5 Oral
1.3 United States Cilostazol Market by Application/End Users
1.3.1 United States Cilostazol Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 United States Cilostazol Market by Region
1.4.1 United States Cilostazol Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Cilostazol Status and Prospect (2012-2022)
1.4.3 Southwest Cilostazol Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Cilostazol Status and Prospect (2012-2022)
1.4.5 New England Cilostazol Status and Prospect (2012-2022)
1.4.6 The South Cilostazol Status and Prospect (2012-2022)
1.4.7 The Midwest Cilostazol Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cilostazol (2012-2022)
1.5.1 United States Cilostazol Sales and Growth Rate (2012-2022)
1.5.2 United States Cilostazol Revenue and Growth Rate (2012-2022)
2 United States Cilostazol Market Competition by Players/Suppliers
2.1 United States Cilostazol Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cilostazol Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cilostazol Average Price by Players/Suppliers (2012-2017)
2.4 United States Cilostazol Market Competitive Situation and Trends
2.4.1 United States Cilostazol Market Concentration Rate
2.4.2 United States Cilostazol Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cilostazol Manufacturing Base Distribution, Sales Area, Product Type
3 United States Cilostazol Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Cilostazol Sales and Market Share by Region (2012-2017)
3.2 United States Cilostazol Revenue and Market Share by Region (2012-2017)
3.3 United States Cilostazol Price by Region (2012-2017)
4 United States Cilostazol Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Cilostazol Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cilostazol Revenue and Market Share by Type (2012-2017)
4.3 United States Cilostazol Price by Type (2012-2017)
4.4 United States Cilostazol Sales Growth Rate by Type (2012-2017)
5 United States Cilostazol Sales (Volume) by Application (2012-2017)
5.1 United States Cilostazol Sales and Market Share by Application (2012-2017)
5.2 United States Cilostazol Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Cilostazol Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cilostazol Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Teva
6.2.2 Cilostazol Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Otsuka Pharmaceutical
6.3.2 Cilostazol Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Cilostazol Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan
6.5.2 Cilostazol Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Squibb
6.6.2 Cilostazol Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Squibb Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Sandoz
6.7.2 Cilostazol Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sandoz Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Hikma Pharmaceuticals
6.8.2 Cilostazol Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 GSK
6.9.2 Cilostazol Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 GSK Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Mayne Pharma
6.10.2 Cilostazol Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Mayne Pharma Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bedford Laboratories
6.12 Abbott
6.13 Takeda
6.14 Zhejiang Weikang Pharmaceutical
6.15 Chongqing Pharscin pharmaceutical
6.16 Chengdu Leer Pharmaceutical
6.17 Yantai Yisheng Pharmaceutical
6.18 Cadila Pharmaceuticals
7 Cilostazol Manufacturing Cost Analysis
7.1 Cilostazol Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cilostazol
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cilostazol Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cilostazol Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Cilostazol Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Cilostazol Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cilostazol Sales Volume Forecast by Type (2017-2022)
11.3 United States Cilostazol Sales Volume Forecast by Application (2017-2022)
11.4 United States Cilostazol Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Cilostazol
Figure United States Cilostazol Market Size (K MT) by Type (2012-2022)
Figure United States Cilostazol Sales Volume Market Share by Type (Product Category) in 2016
Figure Injection Product Picture
Figure Freeze-dried Powder Product Picture
Figure Oral Product Picture
Figure United States Cilostazol Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Cilostazol by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Cilostazol Market Size (Million USD) by Region (2012-2022)
Figure The West Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cilostazol Sales (K MT) and Growth Rate (2012-2022)
Figure United States Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cilostazol Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Cilostazol Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Cilostazol Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cilostazol Sales Share by Players/Suppliers
Figure 2017 United States Cilostazol Sales Share by Players/Suppliers
Figure United States Cilostazol Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cilostazol Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cilostazol Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cilostazol Revenue Share by Players/Suppliers
Figure 2017 United States Cilostazol Revenue Share by Players/Suppliers
Table United States Market Cilostazol Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Cilostazol Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Cilostazol Market Share of Top 3 Players/Suppliers
Figure United States Cilostazol Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cilostazol Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cilostazol Product Category
Table United States Cilostazol Sales (K MT) by Region (2012-2017)
Table United States Cilostazol Sales Share by Region (2012-2017)
Figure United States Cilostazol Sales Share by Region (2012-2017)
Figure United States Cilostazol Sales Market Share by Region in 2016
Table United States Cilostazol Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cilostazol Revenue Share by Region (2012-2017)
Figure United States Cilostazol Revenue Market Share by Region (2012-2017)
Figure United States Cilostazol Revenue Market Share by Region in 2016
Table United States Cilostazol Price (USD/MT) by Region (2012-2017)
Table United States Cilostazol Sales (K MT) by Type (2012-2017)
Table United States Cilostazol Sales Share by Type (2012-2017)
Figure United States Cilostazol Sales Share by Type (2012-2017)
Figure United States Cilostazol Sales Market Share by Type in 2016
Table United States Cilostazol Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cilostazol Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cilostazol by Type (2012-2017)
Figure Revenue Market Share of Cilostazol by Type in 2016
Table United States Cilostazol Price (USD/MT) by Types (2012-2017)
Figure United States Cilostazol Sales Growth Rate by Type (2012-2017)
Table United States Cilostazol Sales (K MT) by Application (2012-2017)
Table United States Cilostazol Sales Market Share by Application (2012-2017)
Figure United States Cilostazol Sales Market Share by Application (2012-2017)
Figure United States Cilostazol Sales Market Share by Application in 2016
Table United States Cilostazol Sales Growth Rate by Application (2012-2017)
Figure United States Cilostazol Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Cilostazol Sales Growth Rate (2012-2017)
Figure Pfizer Cilostazol Sales Market Share in United States (2012-2017)
Figure Pfizer Cilostazol Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Cilostazol Sales Growth Rate (2012-2017)
Figure Teva Cilostazol Sales Market Share in United States (2012-2017)
Figure Teva Cilostazol Revenue Market Share in United States (2012-2017)
Table Otsuka Pharmaceutical Basic Information List
Table Otsuka Pharmaceutical Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Otsuka Pharmaceutical Cilostazol Sales Growth Rate (2012-2017)
Figure Otsuka Pharmaceutical Cilostazol Sales Market Share in United States (2012-2017)
Figure Otsuka Pharmaceutical Cilostazol Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Cilostazol Sales Growth Rate (2012-2017)
Figure Novartis Cilostazol Sales Market Share in United States (2012-2017)
Figure Novartis Cilostazol Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Cilostazol Sales Growth Rate (2012-2017)
Figure Mylan Cilostazol Sales Market Share in United States (2012-2017)
Figure Mylan Cilostazol Revenue Market Share in United States (2012-2017)
Table Squibb Basic Information List
Table Squibb Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Squibb Cilostazol Sales Growth Rate (2012-2017)
Figure Squibb Cilostazol Sales Market Share in United States (2012-2017)
Figure Squibb Cilostazol Revenue Market Share in United States (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sandoz Cilostazol Sales Growth Rate (2012-2017)
Figure Sandoz Cilostazol Sales Market Share in United States (2012-2017)
Figure Sandoz Cilostazol Revenue Market Share in United States (2012-2017)
Table Hikma Pharmaceuticals Basic Information List
Table Hikma Pharmaceuticals Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hikma Pharmaceuticals Cilostazol Sales Growth Rate (2012-2017)
Figure Hikma Pharmaceuticals Cilostazol Sales Market Share in United States (2012-2017)
Figure Hikma Pharmaceuticals Cilostazol Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Cilostazol Sales Growth Rate (2012-2017)
Figure GSK Cilostazol Sales Market Share in United States (2012-2017)
Figure GSK Cilostazol Revenue Market Share in United States (2012-2017)
Table Mayne Pharma Basic Information List
Table Mayne Pharma Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mayne Pharma Cilostazol Sales Growth Rate (2012-2017)
Figure Mayne Pharma Cilostazol Sales Market Share in United States (2012-2017)
Figure Mayne Pharma Cilostazol Revenue Market Share in United States (2012-2017)
Table Bedford Laboratories Basic Information List
Table Abbott Basic Information List
Table Takeda Basic Information List
Table Zhejiang Weikang Pharmaceutical Basic Information List
Table Chongqing Pharscin pharmaceutical Basic Information List
Table Chengdu Leer Pharmaceutical Basic Information List
Table Yantai Yisheng Pharmaceutical Basic Information List
Table Cadila Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cilostazol
Figure Manufacturing Process Analysis of Cilostazol
Figure Cilostazol Industrial Chain Analysis
Table Raw Materials Sources of Cilostazol Major Players/Suppliers in 2016
Table Major Buyers of Cilostazol
Table Distributors/Traders List
Figure United States Cilostazol Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Cilostazol Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cilostazol Price (USD/MT) Trend Forecast (2017-2022)
Table United States Cilostazol Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Cilostazol Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Cilostazol Sales Volume (K MT) Forecast by Type in 2022
Table United States Cilostazol Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Cilostazol Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Cilostazol Sales Volume (K MT) Forecast by Application in 2022
Table United States Cilostazol Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Cilostazol Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cilostazol Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cilostazol Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...